Arthur Kirsch
Director/Miembro de la Junta en LIQUIDIA CORPORATION .
Fortuna: 411 840 $ al 31/05/2024
Cargos activos de Arthur Kirsch
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LIQUIDIA CORPORATION | Director/Miembro de la Junta | 28/06/2020 | - |
Independent Dir/Board Member | 28/06/2020 | - | |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Director/Miembro de la Junta | 13/12/2016 | - |
Independent Dir/Board Member | 13/12/2016 | - | |
Anavasi Diagnostics | Director/Miembro de la Junta | 02/11/2022 | - |
Historial de carrera de Arthur Kirsch
Antiguos cargos conocidos de Arthur Kirsch.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KADMON HOLDINGS, INC. | Director/Miembro de la Junta | 15/05/2019 | 01/11/2021 |
Independent Dir/Board Member | 15/05/2019 | 01/11/2021 | |
OLD API WIND-DOWN LTD. | Presidente | 01/02/2016 | 30/05/2019 |
Independent Dir/Board Member | 01/02/2016 | 30/05/2019 | |
IMMUNOMEDICS, INC. | Director/Miembro de la Junta | 19/08/2015 | 13/10/2016 |
Independent Dir/Board Member | 19/08/2015 | 13/10/2016 | |
POZEN INC. | Director/Miembro de la Junta | 01/05/2004 | 01/06/2015 |
Presidente | 01/06/2015 | 05/02/2016 | |
Independent Dir/Board Member | 01/05/2004 | 01/06/2015 | |
Vector Securities LLC
Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | Director Técnico/Científico/I+D | 01/05/1994 | 01/05/2004 |
Prudential Vector Healthcare Group | Corporate Officer/Principal | 01/01/1999 | 01/01/2001 |
░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formación de Arthur Kirsch.
University of Rhode Island | Undergraduate Degree |
Baruch College | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 14 |
Reino Unido | 2 |
Canadá | 2 |
Operativa
Director/Board Member | 7 |
Independent Dir/Board Member | 6 |
Chairman | 2 |
Sectorial
Health Technology | 7 |
Finance | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LIQUIDIA CORPORATION | Health Technology |
Empresas privadas | 12 |
---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
POZEN, Inc.
POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
PhysioSonics, Inc.
PhysioSonics, Inc. Medical DistributorsDistribution Services PhysioSonics, Inc. developed neurological medical devices. The firm offered products such as transcranial doppler and neuromonitor. It also developed ultrasound for automated monitoring of stroke symptoms. The company was founded in 2000 and was headquartered in Bellevue, WA. | Distribution Services |
Kadmon Holdings, Inc.
Kadmon Holdings, Inc. BiotechnologyHealth Technology Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY. | Health Technology |
Drexel Burnham Lambert, Inc. | Process Industries |
NatWest Securities Ltd. | Finance |
Vector Securities LLC
Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | Finance |
Natwest Securities Corp. | |
Prudential Vector Healthcare Group | Finance |
Old API Wind-down Ltd.
Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Inc. engages in the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the following geographical segments: United States and Canada. The company is founded on December 2, 2015, and is headquartered in Mississauga, Canada. | Health Technology |
Anavasi Diagnostics |
- Bolsa de valores
- Insiders
- Arthur Kirsch
- Experiencia